The MAPK Pathway in Pulmonary Langerhans Cell Histiocytosis
Arch Bronconeumol. 2023 Jun;59(6):347-349.
doi: 10.1016/j.arbres.2022.02.015.
Epub 2022 Apr 27.
[Article in
English,
Spanish]
Affiliations
- 1 Université Paris Cité, FR-75006, INSERM U976 Human Immunology Pathophysiology and Immunotherapy (HIPI), Institut de Recherche Saint-Louis, Paris, France; Department of Pharmacology and Genomics, AP-HP, Hôpital Saint-Louis, Paris, France.
- 2 Université Paris Cité, FR-75006, INSERM U976 Human Immunology Pathophysiology and Immunotherapy (HIPI), Institut de Recherche Saint-Louis, Paris, France; National Reference Centre for Histiocytoses, Department of Pulmonology, AP-HP, Hôpital Saint-Louis, Paris, France. Electronic address: abdellatif.tazi@aphp.fr.
No abstract available
MeSH terms
-
Histiocytosis, Langerhans-Cell* / complications
-
Humans
-
MAP Kinase Signaling System*